We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Review · June 26, 2021

Focal Ablative Therapy Is Not Recommended for Clinically Localised Prostate Cancer

European Urology Oncology

 

Additional Info

European Urology Oncology
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison With Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research
Eur Urol Oncol 2021 Jun 01;4(3)405-423, AS Bates, J Ayers, N Kostakopoulos, T Lumsden, IG Schoots, PM Willemse, Y Yuan, RCN van den Bergh, JP Grummet, HG van der Poel, O Rouvière, L Moris, MG Cumberbatch, M Lardas, M Liew, T Van den Broeck, G Gandaglia, N Fossati, E Briers, M De Santis, S Fanti, S Gillessen, DE Oprea-Lager, G Ploussard, AM Henry, D Tilki, TH van der Kwast, T Wiegel, J N'Dow, MD Mason, P Cornford, N Mottet, TBL Lam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.


Further Reading